BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 16713209)

  • 1. [European network for investigation of medicinal products in children (Medichildren)].
    Pons G
    Arch Pediatr; 2006 Jun; 13(6):631. PubMed ID: 16713209
    [No Abstract]   [Full Text] [Related]  

  • 2. [Network for investigation of medicinal products in children].
    Kassaï B; Treluyer JM; Jacqz-Aigrain E; Pons G
    Arch Pediatr; 2006 Jun; 13(6):631-4. PubMed ID: 16697606
    [No Abstract]   [Full Text] [Related]  

  • 3. [New drugs and European procedures of approval. The European Agency for the Evaluation of Medicinal Products' role].
    Ainsworth MA
    Ugeskr Laeger; 2003 Apr; 165(16):1648-9. PubMed ID: 12756819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric regulatory initiatives.
    Hirschfeld S; Saint-Raymond A
    Handb Exp Pharmacol; 2011; 205():245-68. PubMed ID: 21882115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of the Danish Medical Products Agency in clinical trials].
    Simonsen AC
    Ugeskr Laeger; 2003 Apr; 165(16):1653-6. PubMed ID: 12756821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Who are the PDCO?
    Dempsey EM; Connolly K
    Eur J Pediatr; 2014 Feb; 173(2):233-5. PubMed ID: 23925423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EU law mandates drug testing in children.
    Sinha G
    J Natl Cancer Inst; 2008 Jan; 100(2):84-5. PubMed ID: 18182609
    [No Abstract]   [Full Text] [Related]  

  • 8. [The GCP directive--consequences for clinical drug research].
    Gluud CN
    Ugeskr Laeger; 2003 Apr; 165(16):1662-4. PubMed ID: 12756824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulating clinical trials in Europe.
    Willmott G
    Lancet Oncol; 2013 May; 14(6):453-4. PubMed ID: 23522922
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hospital network in pediatric oncology].
    Doz F
    Arch Pediatr; 2006 Jun; 13(6):635-7. PubMed ID: 16697587
    [No Abstract]   [Full Text] [Related]  

  • 11. Establishing pan-European clinical trials: regulatory compliance and other practical considerations.
    Grienenberger A
    J Biolaw Bus; 2004; 7(4):58-63. PubMed ID: 15675097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Bonne Année", "Gutes Neues Jahr"? Will 2007 be a "Happy New Year" for children's medicines in Europe?
    Stephenson T
    Arch Dis Child; 2007 Aug; 92(8):661-3. PubMed ID: 17642477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performing trials in children with rheumatic diseases: comment on the editorial by Lehman.
    Ruperto N; Martini A; Lovell DJ; Giannini EH; ;
    Arthritis Rheum; 2008 Apr; 58(4):1201-2; author reply 1203. PubMed ID: 18383366
    [No Abstract]   [Full Text] [Related]  

  • 14. [The inspection by the Danish Medical Products Agency of drug clinical trials].
    Jacobsen E; Stilbo I
    Ugeskr Laeger; 2003 Apr; 165(16):1656-8. PubMed ID: 12756822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric medicine. Europe follows U.S. in testing drugs for children.
    Bosch X
    Science; 2005 Sep; 309(5742):1799. PubMed ID: 16166486
    [No Abstract]   [Full Text] [Related]  

  • 16. Diversified harmony: supranational and domestic regulation of pediatric clinical trials in the European Union.
    Pinxten W; Dierickx K; Nys H
    J Cyst Fibros; 2011 Jun; 10 Suppl 2():S183-98. PubMed ID: 21658637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical research: the best or worst of times?
    Ferrara JL; Wingard JR
    Biol Blood Marrow Transplant; 2002; 8(6):293-4. PubMed ID: 12108914
    [No Abstract]   [Full Text] [Related]  

  • 18. Pediatric psychopharmacological research in the post EU regulation 1901/2006 era.
    Schmäl C; Becker K; Berg R; Brünger M; Lehmkuhl G; Oehler KU; Ruppert T; Staudter C; Trott GE; Dittmann RW
    Z Kinder Jugendpsychiatr Psychother; 2014 Nov; 42(6):441-9. PubMed ID: 25335522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical research on humans: regulation in Switzerland, the European Union, and the United States.
    Schott M
    Food Drug Law J; 2005; 60(1):45-77. PubMed ID: 15940854
    [No Abstract]   [Full Text] [Related]  

  • 20. [Increased commercial financing of national Medical Product Agencies within the EU].
    Ramel B
    Lakartidningen; 2003 Jan; 100(5):338-9. PubMed ID: 12607381
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.